127 related articles for article (PubMed ID: 17188646)
1. Immunogenic gangliosides in human ovarian carcinoma.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Santin AD; Bellone S; Saravanan TS; Morton DL
Biochem Biophys Res Commun; 2007 Feb; 353(2):251-8. PubMed ID: 17188646
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-ganglioside IgM antibodies in soft tissue sarcoma: clinical prognostic implications.
Perez CA; Ravindranath MH; Soh D; Gonzales A; Ye W; Morton DL
Cancer J; 2002; 8(5):384-94. PubMed ID: 12416896
[TBL] [Abstract][Full Text] [Related]
3. Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma.
Chu KU; Ravindranath MH; Gonzales A; Nishimoto K; Tam WY; Soh D; Bilchik A; Katopodis N; Morton DL
Cancer; 2000 Apr; 88(8):1828-36. PubMed ID: 10760759
[TBL] [Abstract][Full Text] [Related]
4. Endogenous immune response to gangliosides in patients with confined prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Ye X; Brosman S; Morton DL
Int J Cancer; 2005 Sep; 116(3):368-77. PubMed ID: 15818621
[TBL] [Abstract][Full Text] [Related]
5. Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
Ravindranath MH; Muthugounder S; Hannah MR; Morton DL
Ann N Y Acad Sci; 2007 Jun; 1107():212-22. PubMed ID: 17804549
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
7. Increased levels of gangliosides in the plasma and ascitic fluid of patients with advanced ovarian cancer.
Santin AD; Ravindranath MH; Bellone S; Muthugounder S; Palmieri M; O'Brien TJ; Roman J; Cannon MJ; Pecorelli S
BJOG; 2004 Jun; 111(6):613-8. PubMed ID: 15198791
[TBL] [Abstract][Full Text] [Related]
8. [Ganglioside content and profile in the ovarian tumor tissues and in the biological body fluids of patients].
Novikov AM; Makhova EE; Travnikov ME; Bassalyk LS
Eksp Onkol; 1989; 11(3):52-5. PubMed ID: 2752944
[TBL] [Abstract][Full Text] [Related]
9. Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient.
Ravindranath MH; Muthugounder S; Presser N
Melanoma Res; 2008 Feb; 18(1):47-55. PubMed ID: 18227708
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
Ravindranath MH; Muthugounder S; Presser N; Selvan SR; Portoukalian J; Brosman S; Morton DL
Biochem Biophys Res Commun; 2004 Nov; 324(1):154-65. PubMed ID: 15464996
[TBL] [Abstract][Full Text] [Related]
11. Correlation of gangliosides GM2 and GM3 with metastatic potential to lungs of mouse B16 melanoma.
Saha S; Mohanty KC
J Exp Clin Cancer Res; 2003 Mar; 22(1):125-34. PubMed ID: 12725332
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.
Tai T; Cahan LD; Paulson JC; Saxton RE; Irie RF
J Natl Cancer Inst; 1984 Sep; 73(3):627-33. PubMed ID: 6206271
[TBL] [Abstract][Full Text] [Related]
13. Severe sensory ataxia and demyelinating polyneuropathy with IgM anti-GM2 and GalNAc-GD1A antibodies.
Lopate G; Choksi R; Pestronk A
Muscle Nerve; 2002 Jun; 25(6):828-36. PubMed ID: 12115971
[TBL] [Abstract][Full Text] [Related]
14. Human antiganglioside autoantibodies: validation of ELISA.
Ravindranath MH; Muthugounder S; Saravanan TS; Presser N; Morton DL
Ann N Y Acad Sci; 2005 Jun; 1050():229-42. PubMed ID: 16014538
[TBL] [Abstract][Full Text] [Related]
15. New method for quantitative analysis of GD2 ganglioside in plasma of neuroblastoma patients.
Czaplicki D; Horwacik I; Kowalczyk A; Wieczorek A; Bolek-Marzec K; Balwierz W; Kozik A; Rokita H
Acta Biochim Pol; 2009; 56(3):423-31. PubMed ID: 19724779
[TBL] [Abstract][Full Text] [Related]
16. How useful are anti-neural IgM antibodies in the diagnosis of chronic immune-mediated neuropathies?
Nobile-Orazio E; Gallia F; Terenghi F; Allaria S; Giannotta C; Carpo M
J Neurol Sci; 2008 Mar; 266(1-2):156-63. PubMed ID: 17915254
[TBL] [Abstract][Full Text] [Related]
17. Correlation between soluble Fas level and apoptosis of T cells in ovarian carcinoma.
Ma Y; Ye F; Lv W; Cheng Q; Chen H; Xie X
Eur J Obstet Gynecol Reprod Biol; 2008 Jun; 138(2):204-11. PubMed ID: 17826886
[TBL] [Abstract][Full Text] [Related]
18. Amplified ELISA to detect autoantibodies to N-glycolyl-GM3 ganglioside.
Iznaga N; Carr A; Fernández LE; Solozabal J; Núñez G; Perdomo Y; Morales A
J Clin Lab Immunol; 1996; 48(2):75-85. PubMed ID: 16296265
[TBL] [Abstract][Full Text] [Related]
19. Suppression of Ehrlich ascites tumor growth by immunization with ganglioside GT1b of its origin, its IgM antibody or anti-idiotype of the anti-GT1b IgM.
Saha S; Mondal S
Indian J Exp Biol; 2000 Dec; 38(12):1207-16. PubMed ID: 11411041
[TBL] [Abstract][Full Text] [Related]
20. Correlation of level of gangliosides in plasma with cancer in human patients.
Mondal S; Saha S
J Exp Clin Cancer Res; 2000 Sep; 19(3):317-27. PubMed ID: 11144525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
